Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study

Overview of attention for article published in Lancet Neurology, December 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

So far, Dimensions has found 80 publications that cite this research output.

Article in Annals of Clinical and Translational Neurology (April 2024)

Article in The Lancet Neurology (January 2024)

Book chapter (January 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.